Dopamine Receptor
Dopamine receptors (DR) are members of G protein-coupled receptors superfamily. There are 5 subtypes (D1, D2, D3, D4, D5) of DR which mediate the functions of dopamine in central nervous system for control of locomotion, cognition, and emotion etc.
Products for Dopamine Receptor
- Cat.No. Product Name Information
- GC13853 GBR 12935 dihydrochloride dopamine reuptake inhibitor
- GC12179 GBR 13069 dihydrochloride dopamine uptake inhibitor
- GC41486 Glaucine Glaucine is an alkaloid originally isolated from G.
- GC38022 GR 103691
- GC16903 GR 103691 dopamine D3 receptor antagonist
- GC14593 GSK 789472 hydrochloride dopamine D3 receptor antagonist and D2 partial agonist
- GC19176 GSK163090 GSK163090 is a potent, selective, and orally active 5-HT1A/B/D receptor antagonist with pKi of 9.4/8.5/9.7, and 6.3/6.7 for 5-HT1A/B/D, and dopamine D2/D3, respectively.
- GC30241 GSK598809 GSK598809 is a potent and selective dopamine D3 Receptor (DRD3) antagonist, with a pKi of 8.9.
- GC11243 Halopemide phospholipase D (PLD) inhibitor
- GC17599 Haloperidol Antipsychotic drug
- GC36209 Haloperidol D4 Haloperidol D4 is deuterium labeled haloperidol, and the latter is a potent dopamine D2 receptor antagonist.
- GC36210 Haloperidol D4'
- GC11506 Haloperidol hydrochloride Antipsychotic drug
- GC60915 Hydroxy ziprasidone Hydroxy ziprasidone is an impurity of Ziprasidone.
- GC15463 Iloperidone Dopamine (D2) and serotonin (5HT2) receptor antagonist
- GC10799 Iloperidone hydrochloride D(2)/5-HT(2) receptor antagonistis
- GC17841 JHW 007 hydrochloride Dopamine uptake inhibitor
- GC36370 JNJ-37822681 dihydrochloride JNJ-37822681 dihydrochloride is a potent, specific, centrally active, fast-dissociating dopamine D2 receptor antagonist with a moderate binding affinity for the dopamine D2L receptor (Ki =158 nM), which has potential for the treatment of schizophrenia and bipolar disorder.
- GC60965 Keto Ziprasidone Keto Ziprasidone is an impurity of Ziprasidone.
- GC15619 L-741,626 D2 dopamine receptor selective antagonist
- GC13036 L-741,742 hydrochloride highly potent and selective D4 dopamine receptor antagonist
- GC14569 L-745,870 trihydrochloride highly potent and selective D4 dopamine receptor antagonist
- GC38805 L-745870 L-745870 is a potent, selective, brain-penetrant and orally active dopamine D4 receptor antagonist with a Ki of 0.43 nM.
- GC38806 L-745870 hydrochloride L-745870 hydrochloride is a potent, selective, brain-penetrant and orally active dopamine D4 receptor antagonist with a Ki of 0.43 nM.
- GC14281 L-DOPA methyl ester (hydrochloride) dopamine D1 receptor agonist
- GC17890 LE 300 dopamine D1 receptor antagonist
- GC15095 Levodopa Levodopa (Levodopa) is an orally active metabolic precursor of neurotransmitters dopamine.
- GC15470 Levosulpiride Antipsychotic drug
- GC16730 Lisuride maleate New Product
- GC30797 lumateperone Tosylate (ITI-007) Lumateperone (ITI-007) tosylate is a 5-HT2A receptor antagonist (Ki = 0.54 nM), a partial agonist of presynaptic D2 receptors and an antagonist of postsynaptic D2 receptors (Ki = 32 nM), and a dopamine D1 receptor modulator.
- GC30926 Lurasidone (SM-13496) Lurasidone (SM-13496) (SM-13496) is an antagonist of both dopamine D2 and 5-HT7 with IC50s of 1.68 and 0.495 nM, respectively.
- GC17593 Lurasidone HCl Lurasidone (Hydrochloride) (SM-13496 (Hydrochloride)) is an antagonist of both dopamine D2 and 5-HT7 with IC50s of 1.68 and 0.495 nM, respectively.
- GC63052 LY3154207 LY3154207 is a potent, subtype selective, and orally available human dopamine D1 receptorpositive allosteric modulator (PAM) with minimal allosteric agonist activity (EC50=3 nM).
- GC11182 LY404039 MGlu2 and mGlu3 receptors agonist
- GC63578 Medifoxamine Medifoxamine is a monoamine re-uptake inhibiting antidepressive drug which preferentially inhibits dopamine reuptake.
- GC63550 Mesdopetam hemitartrate Mesdopetam (IRL790) hemitartrate is a dopamine D3 receptor antagonist (Ki=90 nM; IC50=9.8 μM for human recombinant D3 receptor) with psychomotor stabilizing properties.
- GC16249 Metoclopramide Dopamine receptor antagonist
- GC36602 Metoclopramide hydrochloride hydrate
- GC45676 MLS-1547 An agonist of dopamine D2 receptors
- GC30904 Molindone hydrochloride (EN-1733A) Molindone hydrochloride (EN-1733A) (EN-1733A) is a therapeutic antipsychotic, used in the treatment of schizophrenia, works by blocking the effects of dopamine in the brain, leading to diminished psychoses.
-
GC11097
MPTP hydrochloride
MPTP (1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine) is a neurotoxic agent that is a precusor of MPP+ which is toxic to dopaminergic neurons and causes Parkinsonism.
- GC65666 N-Methyldopamine hydrochloride N-Methyldopamine hydrochloride is a precursor of adrenaline in the adrenal medulla. N-Methyldopamine hydrochloride is a modification of the dopamine (DA), and retains agonist activity at the DA1 receptor. N-Methyldopamine hydrochloride remains capable of universal surface coating and secondary reactions using the surface catechols. N-Methyldopamine hydrochloride can be used for heart failure research.
- GC67705 Naxagolide
- GC12543 Nemonapride dopamine D2-like receptor antagonist
- GC31018 NEO 376 (SPI-376) NEO 376 (SPI-376) is a selective modulator of 5-HT1 receptor, GABA receptor and dopamine receptor, with anti-psychotic actively.
- GC36726 Neuromedin N Neuromedin N is a potent modulator of dopamine D2 receptor agonist binding in rat neostriatal membranes.
- GC18068 NGB 2904 NGB 2904 is a potent, selective, orally active and brain-penetrated antagonist of dopamine D3 receptor, with a Ki of 1.4 nM.
- GC14694 NGD 94-1 High affinity D4 receptor ligand
- GC31111 NMI 8739 A conjugate of DHA and dopamine
- GC13573 Nomifensine noradrenalin and dopamine uptake inhibitor
- GC64381 Nomifensine maleate Nomifensine maleate is a selective inhibitor of dopamine uptake, used in adult attention deficit disorder.
- GC17075 NPEC-caged-dopamine Dopamine receptor agonist
- GC31015 NRA-0160 NRA-0160 is a selective dopamine D4 receptor antagonist, with a Ki value of 0.48 nM and with negligible affinity for dopamine D2 receptor (Ki: >10000 nM), D3 receptor (Ki: 39 nM), rat 5-HT2A receptor (Ki: 180 nM) and rat α1 adrenoceptor (Ki: 237 nM).
- GN10607 Nuciferine
- GC31173 Ocaperidone (R79598) Ocaperidone (R79598) is an effective antipsychotic agent, acting as a potent 5-HT2 and dopamine D2 antagonist, and a 5-HT1A agonist, with Kis of 0.14 nM, 0.46 nM, 0.75 nM, 1.6 nM and 5.4 nM for 5-HT2, a1-adrenergic receptor, dopamine D2, histamine H1 and a2-adrenergic receptor, respectively, and a pEC50 and pKi of 7.60 and 8.08 for h5-HT1A.
- GC38405 Odapipam Odapipam (NNC 756) is a selective, high affinity and benzazepine dopamine D1 receptor antagonist with a Kd of 0.18 nM.
- GC12495 Olanzapine Olanzapine (LY170053) is a selective, orally active monoaminergic antagonist with high affinity binding to serotonin H1, 5HT2A/2C, 5HT3, 5HT6 (Ki=7, 4, 11, 57, and 5 nM, respectively), dopamine D1-4 (Ki=11 to 31 nM), muscarinic M1-5 (Ki=1.9-25 nM), and adrenergic α1 receptor (Ki=19 nM).
- GC61809 Olanzapine D3 Olanzapine D3 (LY170053-d3) is the deuterium labeled Olanzapine.
- GC38935 ONC206 ONC206 is an analogue of TRAIL inducer ONC201.
- GC33510 Org-10490 Org-10490 is an antagonist of dopamine D1 receptor and dopamine D2 receptor, used for the treatment for psychiatric disease.
-
GC69634
OS-3-106
OS-3-106 is an effective and selective dopamine D3 receptor (D3R) agonist that can penetrate the blood-brain barrier. It has a high affinity for D3R (Ki = 0.2 nM). OS-3-106 can be used in research on stimulant addiction.
- GC17238 OSU 6162 hydrochloride Dopamine stabilizer
- GC30871 Oxidopamine hydrochloride (6-Hydroxydopamine hydrochloride) Oxidopamine (6-OHDA) hydrochloride is an antagonist of the neurotransmitter dopamine.
- GC10112 Paliperidone Dopamine receptor antagonist
- GC61167 Paliperidone palmitate Paliperidone palmitate (9-Hydroxyrisperidone palmitate), an atypical long-acting antipsychotic agent, is an ester prodrug of Paliperidone.
- GC12800 PAOPA dopamine D2 receptor modulator
- GC31069 Pardoprunox (SLV-308) Pardoprunox (SLV-308) (SLV-308) is a partial dopamine D2 and D3 receptor partial agonist and a serotonin 5-HT1A receptor agonist, with pEC50s of 8, 9.2, and 6.3, respectively.
- GC30980 Pardoprunox hydrochloride (SLV-308 hydrochloride) Pardoprunox (SLV-308) hydrochloride is a partial dopamine D2 and D3 receptor partial agonist and a serotonin 5-HT1A receptor agonist, with pEC50s of 8, 9.2, and 6.3, respectively.
- GC17634 PD 168077 maleate D4 dopamine receptor agonist
- GC14280 PD 168568 dihydrochloride dopamine D4 receptor antagonist
- GC17600 PD128907 HCl Potent and selective dopamine D3 receptor agonist
- GC33730 Pentiapine (CGS 10746) Pentiapine (CGS 10746) (CGS 10746) is a dopamine release inhibitor without binding to synaptic dopamine receptor sites.
- GC16615 Pergolide mesylate Dopaminergic agonist
- GC38231 Pericyazine A typical antipsychotic
- GC39237 Perospirone Perospirone (SM-9018 free base) is an orally active antagonist of 5-HT2A receptor (Ki=0.6 nM) and dopamine D2 receptor (Ki=1.4 nM), and also a partial agonist of 5-HT1A receptor (Ki=2.9 nM).
- GC12293 Perphenazine dopamine antagonist
- GC36875 Perphenazine D8 Dihydrochloride Perphenazine D8 Dihydrochloride is the deuterium labeled Perphenazine, which is a typical antipsychotic drug(5-HT, Dopamine receptor ligand).
- GC65343 PF-06256142 PF-06256142 is a potent, selective, CNS-penetrant and orally active agonist of the D1 receptor, with an EC50 and Ki of 33 nM and 12 nM, respectively.
- GC31225 PF-592379 PF-592379 is a potent dopamine D3 receptor agonist with an EC50 of 21 nM.
- GC11810 PG 01037 dihydrochloride Dopamine D3 receptor antagonist
- GC10643 Pimozide dopamine receptors inhibitor
- GC45756 Pimozide-d4 An internal standard for the quantification of pimozide
- GC67752 Pimozide-d4-1
- GC36924 Pipamperone Pipamperone (Floropipamide; McN-JR 3345; R 3345) is a high-affinity antagonist of 5-HT2A receptor (pKi=8.2) and D4 receptor (pKi=8.0) and a low-affinity antagonist of D2 receptor (pKi=6.7).
- GC31183 Piperidine-MO-1 Piperidine-MO-1 is a modulator of dopamine receptor extracted from patent WO/2005/121087A1, compound example 2; exhibits an ED50 of 68 μmol/kg on increase of DOPAC in the rat striatum.
- GC36929 Piribedil A dopamine receptor agonist
- GC30396 Piribedil D8 (ET-495 D8) Piribedil D8 (ET-495 D8) (ET-495 D8) is the deuterium labeled Piribedil, which is an antiparkinsonian agent.
- GC11602 Piribedil dihydrochloride dopamine agonist
- GC15763 PNU 177864 hydrochloride dopamine D3 receptor antagonist
- GC11902 PNU 96415E dopamine D4 and serotonergic 5-HT2A receptor antagonist
- GC11960 Pramipexole Dopamine agonist
- GC16783 Pramipexole 2HCl Monohydrate Pramipexole 2HCl Monohydrate is a selective and blood-brain barrier (BBB) penetrant dopamine D2-type receptor agonist, with Kis of 2.2 nM, 3.9 nM, 0.5 nM and 1.3 nM for D2-type receptor, D2, D3 and D4 receptors, respectively.
- GC13625 Pramipexole dihydrochloride A dopamine D2S, D2L, D3, and D4 receptor agonist
- GC30854 Pridopidine (ACR16) Pridopidine (ACR16), a dopamine (DA) stabilizer, acts as a low affinity dopamine D2 receptor (D2R) antagonist.
- GC30974 Promazine hydrochloride
- GC68206 Propionylpromazine
- GC39736 Propionylpromazine hydrochloride Propionylpromazine hydrochloride (Propiopromazine hydrochloride), a dopamine receptor D2 (DRD2) antagonist, can be used in the research of Parkinson disease.
- GC68420 Propionylpromazine-d6 hydrochloride
- GC63157 PW0464 PW0464, a nanomolar potent complete G protein biased ligand, is a noncatechol D1R agonist, with an EC50 of 5.8 nM (Gs-cAMP).
- GC14167 Quetiapine